跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
赛治 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Thiamazole Tablets
Approved
化学药品
Thiamazole Tablets
Merck Healthcare Germany GmbH
🇨🇳 National Medical Products Administration
Approval Date
Jul 29, 2022
Approval ID
8Iee0PSxRCZ
Company
Merck Healthcare Germany GmbH
Type
化学药品
Approval Details
Approval Id
8Iee0PSxRCZ
Approval Number
国药准字HJ20171154
Generic Name
甲巯咪唑片
Generic Name En
Thiamazole Tablets
Trade Name
赛治
Drug Type
化学药品
Dosage Form
片剂
Strength
5mg
Reg Date
2022-07-29
Expired Date
2027-07-28
Company Name
Merck Healthcare Germany GmbH
Production Company Name
Merck Healthcare KGaA
Company Detail Path
/organization/merck-healthcare-germany-gmbh
Production Company Detail Path
/organization/merck-healthcare-kgaa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 29, 2022
Approval ID
8Iee0PSxRCZ
Type
化学药品
Back to NMPA Approvals